Alvotech (ALVO) Change in Intangibles (2022 - 2026)
Alvotech's (ALVO) quarterly Change in Intangibles came in at -$16.9 million in Q2 2026, down 12.8% on a YoY basis from -$19.4 million in Q2 2025, and up 56.72% quarter-over-quarter from -$39.1 million in Q1 2026.
Analysis
Alvotech (ALVO) Change in Intangibles (2022 - 2026) Analysis & Trends
Alvotech (ALVO) has reported Change in Intangibles for 5 consecutive years, with -$16.9 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Change in Intangibles fell 12.8% year-over-year to -$16.9 million; the trailing twelve-month figure through Jun 2026 stood at -$72.4 million (down 282.63% YoY), and the FY2025 full-year result was -$31.7 million, down 848.16% from the prior year.
- Change in Intangibles rose to -$16.9 million in Q2 2026 per ALVO's latest filing, from -$39.1 million in the prior quarter.
- Across five years, Change in Intangibles topped out at -$183000.0 in Q1 2025 and bottomed at -$39.1 million in Q1 2026.
- Historically, Change in Intangibles has averaged -$9.0 million across 5 years, with a median of -$7.0 million in 2025.
- The sharpest annual moves came in 2024 and 2026: Change in Intangibles jumped 74.78% in 2024, then sank 21240.44% in 2026.
- Over 5 years, Change in Intangibles stood at -$11.1 million in 2022, then retreated by 19.03% to -$13.2 million in 2023, then surged by 74.78% to -$3.3 million in 2024, then plunged by 110.45% to -$7.0 million in 2025, then tumbled by 140.54% to -$16.9 million in 2026.
- According to Business Quant data, Change in Intangibles over the past three periods registered -$16.9 million, -$39.1 million, and -$7.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn | - |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn | - |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn | 22.34 Mn |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn | - |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn | - |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | -16.90 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | - |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn | - |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn | - |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -16.90 Mn |
| Mar 31, 2026 | -39.05 Mn |
| Dec 31, 2025 | -7.03 Mn |
| Sep 30, 2025 | -9.46 Mn |
| Jun 30, 2025 | -14.99 Mn |
| Mar 31, 2025 | -183,000.00 |
| Dec 31, 2024 | -3.34 Mn |
| Sep 30, 2024 | -427,000.00 |
| Jun 30, 2024 | -887,000.00 |
| Mar 31, 2024 | -543,000.00 |
| Dec 31, 2023 | -13.24 Mn |
| Jun 30, 2023 | -216,000.00 |
| Dec 31, 2022 | -11.12 Mn |